Related Experiment Videos
Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells
M Piacentini1, L Fesus, G Melino
1Department of Biology, University of Rome Tor Vergata, Italy.
FEBS Letters
|April 5, 1993
Summary
This study shows that both cisplatin and retinoic acid trigger apoptosis in neuroblastoma cells. These agents induce programmed cell death at different cell cycle stages, suggesting multiple pathways for apoptosis initiation.
Area of Science:
- Neuroscience
- Cell Biology
- Cancer Research
Background:
- Neuroblastoma is a pediatric cancer with complex cell cycle regulation.
- Apoptosis, or programmed cell death, is a critical process in cancer therapy.
- Understanding apoptosis induction in cancer cells is key to developing effective treatments.
Purpose of the Study:
- To investigate the induction of apoptosis in the human neuroblastoma cell line SK-N-BE(2) using cisplatin and retinoic acid.
- To determine the relationship between apoptosis induction and cell cycle progression.
- To identify potential cell cycle start points for the apoptotic death program.
Main Methods:
- Monitoring apoptosis by counting apoptotic bodies.
- Evaluating the activity of 'tissue' transglutaminase (a marker of apoptosis).
- Analyzing cell cycle phase distribution using flow cytometry (implied).
Main Results:
- Both cisplatin and retinoic acid significantly enhance apoptosis in SK-N-BE(2) cells.
- Retinoic acid treatment leads to cell cycle arrest in the G1 phase.
- Cisplatin treatment results in cell cycle arrest in the G2/M phase.
Conclusions:
- Apoptosis can be induced in neuroblastoma cells by distinct agents acting at different cell cycle phases.
- The findings suggest the existence of multiple initiation points for apoptosis within the neuroblastoma cell cycle.
- This provides insights into targeted therapeutic strategies for neuroblastoma.